RNA Technologies and Therapeutics

RNA Technologies and Therapeutics Inc. specializes in the design, optimization, and small-mid scale production (mg to g) of high-quality RNA including nucleoside modified messenger RNA, RNA and LNP formulations and the development of mRNA-based technologies and targeted therapeutics. We are committed to address infrastructural barrier to clinical and translational research in vaccine development, gene therapy, stem cell reprogramming, and other non-viral gene therapy-based applications by providing high quality in vitro transcribed RNA (e.g., mRNA, lncRNA), and targeted LNPs, to the biotech industry, and academic partners. RNA Technologies Services Our services include: • Off the shelf reporter RNA (Luciferase, eGFP, mCherry) • High throughput RNA sequence screening, hundreds of variants of a sequence can be produced for rapid screening in therapeutic applications. • Large scale custom RNA synthesis: with sized ranging from a few hundred nucleotides, up to 5000 nt. • Codon and sequence optimization for better expression. • UTR optimization for better translation efficiency. • Encapsulation in commercially available LNP. • Quality control for RNA integrity, capping efficiency, transcription accuracy & dsRNA removal. RNA Therapeutics Services Collaboration is at the heart of our DNA at RNA T&T. We believe that meaningful partnerships are essential to drive innovation and accelerate progress. We take pride in our dynamic network of alliances with leading research institutions, industry pioneers, and visionary minds. These collaborations serve as catalysts for ground-breaking discoveries and transformative solutions. As a nimble and forward-thinking company, we embrace fresh perspectives and welcome new opportunities for collaboration. Whether you're an emerging talent, an established entity, or an ingenious entrepreneur, we invite you to contact us to discuss how we can collectively shape the future of RNA technology and its applications.